André Augusto Lemos Vidal de Negreiros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
André Augusto Lemos Vidal de Negreiros has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alfredo Damasceno
Universidade de Campinas (UNICAMP), Brazil
4 shared publications - Ana Carolina Amaral de Andrade
University of Campinas (UNICAMP)
4 shared publications - Gabriel de Deus Vieira
Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Laboratório de Neuroimagem, Campinas SP, Brazil
4 shared publications - Mariana Moreira Soares de Sá
University of Campinas (UNICAMP)
4 shared publications - Arthur de Medeiros Dias
University of Campinas (UNICAMP)
3 shared publications - Rafael Gemaque Lima Bentes
University of Campinas (UNICAMP)
3 shared publications
Latest Publications
- 12 November 2024
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 92, 106172
Patterns of cognitive decline across different multiple sclerosis clinical courses
- 12 November 2024
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 92, 106172
Patterns of cognitive decline across different multiple sclerosis clinical courses
- Open Access
- 1 August 2024
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (S 01) , S1-S52
Cognitive progression independent of relapse activity in different multiple sclerosis phenotypes
Address for correspondence: Andre Augusto Lemos Vidal de Negreiros (email: andrevidaldenegreiros@gmail.com). Abstract Background: It is unclear whether patients with progressive multiple sclerosis (PMS) present a distinct pattern of cognitive impairment (CI); whether the progression independent of relapse activity (PIRA) impacts CI; and how different is PIRA across relapsing-remitting MS (RRMS) and PMS. Objective: To assess the trajectories of cognitive/clinical decline in RRMS/PMS patients, evaluating the association of neuroimaging parameters and reserve, and also characterizing according to PIRA. Methods: Longitudinal four-year follow-up that was conducted in the MS center of a tertiary hospital. In total, 54 patients were enrolled (30 with PMS and 24 with RRMS) who underwent brain MRI, clinical and neuropsychological evaluations (BRB-N, Tower of London Test, and Boston Naming Test) at baseline (time 1) and after 4 years (time 2). The evaluations of cortical thickness and subcortical volumes were performed using Freesurfer. The Spinal Cord Toolbox was used to evaluate the area of spinal cord (SC) section at the C2 level. Results: At time 1, 37.2% of the individuals presented CI and, at time 2, 52.4%. There were no major differences between the RRMS and PMS groups in the evolution of clinical, cognitive and radiological variables after 4 years of follow-up. For the worsening of clinical disability, the best predictive factors were the SC area and the striatum volume. For cognitive deterioration, striatum volume and cortical thickness were the best predictors. We observed PIRA in 65.11% of the patients: CI was observed in 46.5% at time 1, and, at time 2, in 59.2%, and there were no major differences between MS groups in terms of the clinical, cognitive or neuroimaging variables. Conclusion: There were no major differences between MS groups in the trajectories of clinical, cognitive and neuroimaging variables, pointing to a uniformity in the clinical courses of the disease. The similar trajectories across the RRMS and PMS groups with PIRA may suggest a common mechanism driving progression. Article published online: 02 October 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
- 1 August 2024
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (S 01) , S1-S52
Open AccessCognitive progression independent of relapse activity in different multiple sclerosis phenotypes
Address for correspondence: Andre Augusto Lemos Vidal de Negreiros (email: andrevidaldenegreiros@gmail.com). Abstract Background: It is unclear whether patients with progressive multiple sclerosis (PMS) present a distinct pattern of cognitive impairment (CI); whether the progression independent of relapse activity (PIRA) impacts CI; and how different is PIRA across relapsing-remitting MS (RRMS) and PMS. Objective: To assess the trajectories of cognitive/clinical decline in RRMS/PMS patients, evaluating the association of neuroimaging parameters and reserve, and also characterizing according to PIRA. Methods: Longitudinal four-year follow-up that was conducted in the MS center of a tertiary hospital. In total, 54 patients were enrolled (30 with PMS and 24 with RRMS) who underwent brain MRI, clinical and neuropsychological evaluations (BRB-N, Tower of London Test, and Boston Naming Test) at baseline (time 1) and after 4 years (time 2). The evaluations of cortical thickness and subcortical volumes were performed using Freesurfer. The Spinal Cord Toolbox was used to evaluate the area of spinal cord (SC) section at the C2 level. Results: At time 1, 37.2% of the individuals presented CI and, at time 2, 52.4%. There were no major differences between the RRMS and PMS groups in the evolution of clinical, cognitive and radiological variables after 4 years of follow-up. For the worsening of clinical disability, the best predictive factors were the SC area and the striatum volume. For cognitive deterioration, striatum volume and cortical thickness were the best predictors. We observed PIRA in 65.11% of the patients: CI was observed in 46.5% at time 1, and, at time 2, in 59.2%, and there were no major differences between MS groups in terms of the clinical, cognitive or neuroimaging variables. Conclusion: There were no major differences between MS groups in the trajectories of clinical, cognitive and neuroimaging variables, pointing to a uniformity in the clinical courses of the disease. The similar trajectories across the RRMS and PMS groups with PIRA may suggest a common mechanism driving progression. Article published online: 02 October 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
- Open Access
- 30 October 2023
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 21, eAI0538
Cortical ribbon sign on neuroimaging in a patient with hepatic encephalopathy secondary to herbal medicine usage
The use of herbal medicines is growing exponentially despite the lack of scientific evidence regarding their effectivity and toxicity. ( , ) Moreover, the use of herbal medicines have been reported to be common in patients with chronic liver disease (30–62%); these medicines can lead to hepatotoxicity and serious hepatic side effects. ( ) Hepatic encephalopathy is a complication of acute liver failure and chronic liver disease that causes cognitive dysfunction, motor deficits, and seizures. ( , ) Gastrointestinal hemorrhage,
- 30 October 2023
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 21, eAI0538
Open AccessCortical ribbon sign on neuroimaging in a patient with hepatic encephalopathy secondary to herbal medicine usage
The use of herbal medicines is growing exponentially despite the lack of scientific evidence regarding their effectivity and toxicity. ( , ) Moreover, the use of herbal medicines have been reported to be common in patients with chronic liver disease (30–62%); these medicines can lead to hepatotoxicity and serious hepatic side effects. ( ) Hepatic encephalopathy is a complication of acute liver failure and chronic liver disease that causes cognitive dysfunction, motor deficits, and seizures. ( , ) Gastrointestinal hemorrhage,
- Open Access
- 1 September 2015
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 73 (9) , 741-745
Clinical and epidemiological profile of patients diagnosed with multiple sclerosis in João Pessoa, Paraíba, Brazil
Prevalence rates of multiple sclerosis (MS) suggest an interrelationship between genetic and environmental factors, ranging worldwide.
- 1 September 2015
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 73 (9) , 741-745
Open AccessClinical and epidemiological profile of patients diagnosed with multiple sclerosis in João Pessoa, Paraíba, Brazil
Prevalence rates of multiple sclerosis (MS) suggest an interrelationship between genetic and environmental factors, ranging worldwide.